US · Healthcare

Connect Biopharma Holdings Ltd (CNTB)

Biotechnology

Connect Biopharma Holdings Ltd (CNTB) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for CNTB

P/E ratio

18.00

Connect Biopharma Holdings Ltd (CNTB) — FAQ

What is CNTB's P/E ratio?

The price-to-earnings (P/E) ratio for Connect Biopharma Holdings Ltd (CNTB) is 18.00 (data as of 2026-03-24).

Does Connect Biopharma Holdings Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Connect Biopharma Holdings Ltd (CNTB). Check the MyAverix Finance app for the latest dividend data.

What sector is Connect Biopharma Holdings Ltd in?

Connect Biopharma Holdings Ltd (CNTB) is classified in the Healthcare sector (Biotechnology industry).

What exchange is CNTB listed on?

CNTB is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)